Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 2154
Journal of Biotechnology & Biomaterials received 2154 citations as per Google Scholar report
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- ResearchBible
- China National Knowledge Infrastructure (CNKI)
- Access to Global Online Research in Agriculture (AGORA)
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
In Association with
Martin J. D Souza
Professor & Director
College of Pharmacy & Health Sciences
Mercer University- Atlanta
USA
Biography
Dr. Dsouza is a professor and Director of Graduate Programs in the Department of Pharmaceutical Sciences at Mercer University. In addition, he is also director of the Mercer Clinical Laboratory and Co-Director of the Center for Drug Delivery Research.
Research Interest
Currently we are also working on oral delivery of vaccines, proteins and peptides. The strategy is to prepare sustained release nanosphere/microsphere formulations which are enteric coated so as to prevent degradation in the stomach. We have recently formulated and have conducted preliminary testing of the efficacy after oral vaccination in cancers such as melanoma, breast, ovarian and prostate. We are also evaluating the efficacy of viral and bacterial vaccines such as TB, Typhoid, Pneumococcal, Hepatitis B, Influenza, HIV and H1N1 vaccines. Recently, we have also been working on the delivery of vaccines and proteins via the transdermal route with the use of DermarollersR and microneedle technology. Several patents related to the research mentioned have been issued/filed and variousgrants have been awarded. We welcome collaborations in these and related areas of research.
Certificate
